Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 11, 2019
Reporting Period: Event date December 11, 2019; Closing expected on or about December 30, 2019.
The Company entered into a Common Stock Purchase Agreement with certain accredited investors for a private placement of common stock. The transaction is exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or margin data. The following capital raise metrics are disclosed:
- Shares Issued: 21,071,143 shares of Common Stock.
- Purchase Price: $0.14 per share.
- Total Proceeds: Approximately $2,950,000 (calculated as 21,071,143 shares x $0.14).
- Use of Proceeds: Working capital and general corporate purposes.
Material Changes
The primary material change is the execution of the Common Stock Purchase Agreement and the Registration Rights Agreement. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the proceeds for working capital and general corporate purposes. A registration statement is required to be filed with the SEC by April 30, 2020, to register the shares sold to purchasers.
Risks and Contingencies:
- Forward-Looking Statements: The filing contains forward-looking statements regarding the timing of the closing, anticipated proceeds, and future financial performance. Actual results may differ materially due to risks and uncertainties.
- Registration Rights: The shares are not registered and may not be sold in the U.S. absent registration or an exemption.
- Closing Conditions: The transaction is subject to the satisfaction of customary closing conditions.
Investor Verification Checklist
- Verify the actual closing date and confirmation of fund receipt (expected on or about December 30, 2019).
- Confirm the filing of the registration statement by the April 30, 2020 deadline as per the Registration Rights Agreement.
- Review the full text of the Common Stock Purchase Agreement (Exhibit 10.1) for specific covenants and indemnification rights.
- Check subsequent filings for updates on the use of proceeds and any changes to the capital structure.